Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Research progress on the oxazolidinone drug linezolid resistance.

1 Sept 2020

Abstract excerpt

OBJECTIVE: The oxazolidinone drug linezolid is mainly used for severe infections caused by multidrug-resistant Gram-positive bacteria. However, emerging linezolid resistance is aggravating difficulties in the treatment of certain infectious diseases. The objective of this review was to provide a reference for researchers and clinicians to be able to better face together the serious challenge of antimicrobial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Bacterial biofilms and quorum sensing

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33015768
DOI: 10.26355/eurrev_202009_23009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Research progress on the oxazolidinone drug linezolid resistance.PMID 33015768Read ↗

Molecular characteristics of oxazolidinone resistance in enterococci from a multicenter study in ChinaSemantic proximity Read ↗

Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015)Semantic proximity Read ↗

Oxazolidinones: mechanisms of resistance and mobile genetic elements involvedSemantic proximity Read ↗

ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries.Semantic proximity Read ↗

Genomic epidemiology reveals multiple mechanisms of linezolid resistance in clinical enterococci in ChinaSemantic proximity Read ↗

Mapping the widespread distribution and transmission dynamics of linezolid resistance in humans, animals, and the environmentSemantic proximity Read ↗

Investigation of mechanism and molecular epidemiology of linezolid-resistant Enterococcus faecalis in China.Semantic proximity Read ↗

Linezolid in the Focus of Antimicrobial Resistance of Enterococcus Species: A Global Overview of Genomic StudiesSemantic proximity Read ↗

Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, ChinaSemantic proximity Read ↗

Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.Semantic proximity Read ↗

ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countriesSemantic proximity Read ↗

The emerging problem of linezolid-resistant enterococci.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.